Micro and Nanoparticles as Carriers for Streptokinase: A Mini-Review on Efficacy, Side Effects and Pharmacokinetics
A Amani - Nanomedicine Research Journal, 2024 - nanomedicine-rj.com
Streptokinase is being successfully used as a thrombolytic agent for restoring the blood flow
following thromboembolism and myocardial infarction. However, high immunogenicity of the …
following thromboembolism and myocardial infarction. However, high immunogenicity of the …
[PDF][PDF] Micro and Nanoparticles as Carriers for Streptokinase: A Mini-Review on Efficacy, Side Effects and Pharmacokinetics
A Amani - nanomedicine-rj.com
Globally, the leading cause of death is considered to be cardiovascular diseases (CVDs). In
2019, around 17.9 million deaths (~ 32% of all deaths) were estimated to be due to CVDs …
2019, around 17.9 million deaths (~ 32% of all deaths) were estimated to be due to CVDs …